• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周血候选基因表达谱在宫颈癌筛查中的研究。

Discovery of candidate gene expression signatures in peripheral blood for the screening of cervical cancer.

机构信息

Department of Biotechnology, Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, China.

Department of Hematology, The Second Affiliated Hospital of Henan University of Chinese Medicine (The Henan Province Hospital of Traditional Chinese Medicine), 6 Dongfeng Road, Zhengzhou 450002, China.

出版信息

Biomark Med. 2020 Feb;14(2):109-118. doi: 10.2217/bmm-2019-0247. Epub 2020 Feb 17.

DOI:10.2217/bmm-2019-0247
PMID:32064895
Abstract

To investigate whether cervical cancer (CC) and cervical intraepithelial neoplasia (CIN) can be screened by analyzing gene expression profiling of peripheral blood. RNA-sequencing analysis of blood was performed on 11 CC patients, 21 CIN patients and 19 healthy controls (H). Fifty-nine genes were validated by quantitative real-time PCR using blood samples from 46 H, 83 CC and 32 CIN patients. There were significant differences in the expression levels of six genes between CC and H, five genes between CIN and H and four genes between CC and CIN (p < 0.05). Four genes discriminated cervical lesions from H with a sensitivity of 82.61%, a specificity of 87.83% and an area under the curve of 0.8981. Three genes discriminated CC from CIN with a sensitivity of 53.13%, a specificity of 96.39% and an area under the curve of 0.7786. Our findings provided a promising noninvasive quantitative real-time PCR diagnostic assay of CC and CIN.

摘要

为了探讨是否可以通过分析外周血基因表达谱来筛查宫颈癌(CC)和宫颈上皮内瘤变(CIN)。对 11 例 CC 患者、21 例 CIN 患者和 19 例健康对照者(H)的血液进行 RNA 测序分析。使用来自 46 例 H、83 例 CC 和 32 例 CIN 患者的血液样本,通过定量实时 PCR 验证了 59 个基因。在 CC 和 H 之间、CIN 和 H 之间以及 CC 和 CIN 之间,有 6 个基因、5 个基因和 4 个基因的表达水平存在显著差异(p<0.05)。有 4 个基因能够以 82.61%的灵敏度、87.83%的特异性和 0.8981 的曲线下面积将宫颈病变与 H 区分开来。有 3 个基因能够以 53.13%的灵敏度、96.39%的特异性和 0.7786 的曲线下面积将 CC 与 CIN 区分开来。我们的研究结果为 CC 和 CIN 的非侵入性定量实时 PCR 诊断检测提供了有前景的方法。

相似文献

1
Discovery of candidate gene expression signatures in peripheral blood for the screening of cervical cancer.外周血候选基因表达谱在宫颈癌筛查中的研究。
Biomark Med. 2020 Feb;14(2):109-118. doi: 10.2217/bmm-2019-0247. Epub 2020 Feb 17.
2
MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.液体活检中高级别宫颈上皮内瘤变的 microRNA 生物标志物。
Biomed Res Int. 2021 Apr 13;2021:6650966. doi: 10.1155/2021/6650966. eCollection 2021.
3
Construction of a diagnostic classifier for cervical intraepithelial neoplasia and cervical cancer based on XGBoost feature selection and random forest model.基于 XGBoost 特征选择和随机森林模型构建用于宫颈上皮内瘤变和宫颈癌的诊断分类器。
J Obstet Gynaecol Res. 2023 Jan;49(1):296-303. doi: 10.1111/jog.15458. Epub 2022 Oct 11.
4
Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?液基细胞学标本中人类端粒酶基因和C-MYC的基因组扩增能否用作机会性宫颈癌筛查的方法?
Gynecol Obstet Invest. 2015;80(3):153-63. doi: 10.1159/000371760. Epub 2015 Apr 1.
5
Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.血清miR-182作为宫颈癌诊断和预后标志物的研究。
Technol Health Care. 2024;32(5):3083-3095. doi: 10.3233/THC-231681.
6
Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.外泌体 let-7d-3p 和 miR-30d-5p 作为宫颈癌及其前体非侵入性筛查的诊断生物标志物。
Mol Cancer. 2019 Apr 2;18(1):76. doi: 10.1186/s12943-019-0999-x.
7
Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.对宫颈上皮内瘤变和宫颈癌的综合基因组变异进行分析,为宫颈癌的早期预警确定了潜在的靶点。
J Med Genet. 2019 Mar;56(3):186-194. doi: 10.1136/jmedgenet-2018-105745. Epub 2018 Dec 19.
8
Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.miR-21、miR-26b、miR-221/222 和 miR-126 基因多态性与宫颈上皮内瘤变和宫颈癌关系的相关性研究。
BMC Cancer. 2021 Sep 7;21(1):997. doi: 10.1186/s12885-021-08743-2.
9
Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.hsa-miR-124、SOX1、TERT 和 LMX1A 基因甲基化作为宫颈癌前病变的生物标志物。
Gynecol Oncol. 2018 Sep;150(3):545-551. doi: 10.1016/j.ygyno.2018.06.014. Epub 2018 Jun 28.
10
Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.预测宫颈鳞状细胞癌的 miRNA-mRNA 功能协同网络。
FEBS Open Bio. 2019 Dec;9(12):2080-2092. doi: 10.1002/2211-5463.12747. Epub 2019 Nov 17.

引用本文的文献

1
In silico drug repurposing for potential HPV-induced skin wart treatment - A comparative transcriptome analysis.用于潜在人乳头瘤病毒诱导的皮肤疣治疗的计算机药物再利用——一项比较转录组分析
J Genet Eng Biotechnol. 2025 Jun;23(2):100485. doi: 10.1016/j.jgeb.2025.100485. Epub 2025 Mar 29.
2
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening.目前应用于宫颈癌筛查的原发性人乳头瘤病毒检测方法
Life (Basel). 2020 Nov 19;10(11):290. doi: 10.3390/life10110290.